Study to Investigate the Safety, Tolerability and Efficacy of YH4808 in Patients With Reflux Esophagitis
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study is to investigate the optimal clinical dose and administration methods of YH4808
in patients with reflux esophagitis by evaluating the safety and efficacy after YH4808 oral
administration.